Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
boston blog main
cancer
4
×
europe blog main
4
×
life sciences
national blog main
san francisco blog main
boston top stories
europe top stories
fda
indiana blog main
indiana top stories
national top stories
novartis
san francisco top stories
biogen
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer drugs
clinical trials
deerfield management
detroit blog main
detroit top stories
eli lilly
gilead sciences
ipo
melinta therapeutics
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
What
medicines
4
×
ipo
bio
cancer
covid
drug
fda
new
roundup
acquisitions
activity
address
announced
approval
approvals
approves
biogen
biotech
black
blueprint
carries
ceo
certain
clamped
clinic
collabs
companies
daniel
deal
delays
designed
developing
diamond
economic
eluded
fast
genetic
gilead
gilead’s
help
Language
unset
Current search:
medicines
×
photo
×
cancer
×
" europe blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic